Atlas Trials

Cantharidin and Occlusion in Verruca Epithelium

Clinical trial NCT03487549 · COMPLETED

Trial details

NCT number
NCT03487549
Sponsor
Verrica Pharmaceuticals Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Common WartWarts HandWartsPapillomavirus InfectionsDNA Virus InfectionsSkin Diseases, ViralSkin Diseases, InfectiousSkin DiseasesVirus DiseasesTumor Virus InfectionsVerruca VulgarisVerruca
Start date
2018-03-27
Primary completion
2019-05-16
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.